A sensor developed by Hans Gregersen and his team at California Medical Innovations Institute, funded by the SPARC program, has received FDA 510(k) clearance.
This device, designed to measure colonic motility and anorectal function, holds promise for improving neuromodulation studies. While the device's listing is pending on the FDA 510(k) database, this milestone represents a significant advancement.
Dr. Gregersen will discuss his team's experience in bringing the device from design to clearance On the winding road of commercialization of a SPARC supported device, on May 14th. Register here.
